Nano Dimension have filed for a patent pertaining to the production of bioartificial materials using their trademark inkjet technology. This makes Nano Dimension one of a growing number of companies dipping their toes into the bio-printing field. The inkjet technology enables them to print complex biological structures made up of cells and inks.
The patent is registered under the company’s Nano Dimension Technologies subdivision. Bioartificial structures allow for the design, modification, growth and maintenance of living tissues embedded in natural or synthetic scaffolds to enable them to perform complex biochemical functions. This particular patent is specifically based on the production of structures that mimic nephrons, a part of the kidneys with the purpose of filtering blood.
Medical professionals may apply the technology to kidney transplants. It has the potential to develop the field of artificial organ production as well. The ability to produce new parts of organs that are often hard to find donors for is a landmark achievement in the field of medicine. It also means that it can be valuable to the field of toxicology. This is because researchers can more effectively understand the mechanics of kidneys and the body’s filtration system.
About Nano Dimension
Founded in 2012, Nano Dimension’s core focus has been on the advancement of Additive Manufacturing. While the company is most famous for producing 3D printers for the express purpose of creating printed circuity boards, they have expanded their portfolio and dived into other activities pertaining to additive manufacturing.
They have also produced nanotechnology-based conductive and dielectric inks. Their expertise in nanotechnology makes them a natural fit for the shift towards bioprinting.
The company is based in Israel and in America. Their stocks are available in both countries. The company has filed for many different patents over the past few years. It is as of yet unknown when the patent office will grant Nano Dimension the rights to this new technology.